ABL BIOTEC A/S: Financial statements 2020
CVR: 50811018
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -115,992 and a net result of DKK 2,455,230 compared with DKK 3,308,337 the year before. Equity in the 2020 report amounted to DKK 26,577,060. The solvency ratio was 96.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -115,992
- Profit/Loss
- DKK 2,455,230
- Equity
- DKK 26,577,060
- Total Assets
- DKK 27,478,747
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -116K | 2.5M | 26.6M | 1 |
| 2019 | - | -114K | 3.3M | 24.7M | 1 |
| 2018 | - | -109K | -2M | 21.5M | 1 |
| 2017 | - | -125K | 1.1M | 24.6M | 1 |
| 2016 | - | -118K | 796K | 24.5M | 1 |
Official annual report
How creditworthy is ABL BIOTEC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ABL BIOTEC A/S has published its annual report for 2019. Gross profit came to DKK -114,364, and the net result was DKK 3,308,337.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.
